Relmada Therapeutics Inc share price logo

Relmada Therapeutics Inc Share Price

NASDAQ: RLMD

Small Cap

$7.24

+0.03

(+0.42%)

Live

as on

Relmada Therapeutics Inc Stock Performance

as on April 28, 2026 at 2:13 am IST

  • Day's Low

    Day's High

    $7.11
    $7.59
    downward going graph

    1.80%

    Downside

    4.83%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.27
    $7.94
    downward going graph

    96.31%

    Downside

    9.67%

    Upside

    downward going graph

Relmada Therapeutics Inc share price movements today

Previous Close
$7.21
Open
$7.21
Volume
423.8K
Day's Low - High
$7.11 - $7.59
52 Week Low - High
$0.27 - $7.94

Relmada Therapeutics Inc Historical Returns

1 Month Return
+ 12.13 %
3 Month Return
+ 75.85 %
1 Year Return
+ 1017.66 %
3 Year Return
+ 163.14 %
5 Year Return
-81.4 %

Relmada Therapeutics Inc Stock Fundamentals & Key Indicators

Check Relmada Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$756.3M

EPS (TTM)

-0.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-13.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-25.63%

Relmada Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Relmada Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$756.3M-81.4%NA0.00%
BUY$40.8B116.23%131.78.45%
BUY$109.5B99.64%28.132.94%
NA$33.4BNA121.785.37%
BUY$79.5B52.82%18.1131.41%

Stock Returns calculator for Relmada Therapeutics Inc Stock including INR - Dollar returns

The Relmada Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Relmada Therapeutics Inc investment value today

Current value as on today

₹12,31,917

Returns

₹11,31,917

(+1.13K%)

Returns from Relmada Therapeutics Inc Stock

₹10,13,846 (+1.01K%)

Dollar Impact

₹1,18,071 (+118.07%)

Analyst Recommendation on Relmada Therapeutics Inc Stock

Based on 11 analysts

BUY

63.64%

Buy

36.36%

Hold

0.00%

Sell

Based on 11 analysts, 63.64% of analysts recommend a 'BUY' rating for Relmada Therapeutics Inc. Average target price of $12.8

Relmada Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Relmada Therapeutics Inc.

What analysts predicted

43.44%UPSIDE

Target Price

$12.8

Current Price

$7.24

Analyzed by

11 Analysts

Target

$12.80

Relmada Therapeutics Inc target price $12.8, a slight upside of 43.44% compared to current price of $7.24. According to 11 analysts rating.

Relmada Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Relmada Therapeutics Inc Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Relmada Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-22
-26
-22
-18
-23
-19
-18
-10
-10
-20
EBITDA
-22
-25
-22
-18
0
-18
-18
-10
-10
-20
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-22
-25
-21
-17
-21
-18
-17
-9
-10
-19
Income Tax Expense
-1
0
-22
-18
-
-
-
-
-
-
Net Income
-22
-25
-21
-17
-21
-18
-17
-9
-10
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Relmada Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Jun 2021
Dec 2021
Jun 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
-
0
-
-
-
-
-
Operating Income
-60
-
-125
-
-161
-103
-83
-59
EBITDA
-59
-
-125
-
-161
4
-83
-59
Interest Expense
1
-
0
-
4
-
-
-
Depreciation
0
-
0
-
-
-
-
-
Income Before Tax
-59
-
-125
-
-157
-98
-79
-57
Income Tax Expense
-1
-
0
-
-2
0
-
-
Net Income
-59
-59
-125
-125
-157
-98
-79
-57
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Relmada Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-25
-21
-17
-21
-18
-17
-9
-10
37
Operating Cash Flow
-10
-13
-13
-16
-8
-18
-6
-6
-14
Investing Cash Flow
7
10
14
16
11
15
6
6
-76
Financing Cash Flow
0
0
-
0
0
-
0
-
93
Change in Cash
-2
-2
0
0
2
-2
0
0
2

Relmada Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-8
0
-59
-125
-157
-98
-79
-57
Operating Cash Flow
-6
-6
0
-27
-91
-103
-51
-51
-45
Investing Cash Flow
0
0
0
-34
-54
19
50
51
-48
Financing Cash Flow
0
6
0
28
187
45
0
0
93
Change in Cash
-6
0
0
-33
41
-39
-1
0
0

Global Institutional Holdings in Relmada Therapeutics Inc

Funds
Holdings
Opaleye Management Inc
0.89%
BOOTHBAY FUND MANAGEMENT, LLC
0.8%
UBS Group AG
0.54%
RBF LLC
0.49%
Marshall Wace Asset Management Ltd
3.04%

Relmada Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 09 March

    Mon, 06:18 PM

    -

    Relmada Therapeutics shares rise after promising Phase 2 trial data for NDV-01 in bladder cancer treatment.

Insights on Relmada Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RLMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, RLMD stock has moved up by 1017.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RLMD has outperformed top 5 stocks with highest market-cap in its industry

About Relmada Therapeutics Inc

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
OrganisationRelmada Therapeutics Inc
Headquarters2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134
IndustryBiotechnology
CEODr. Sergio Traversa M.B.A., Pharm.D.
E-voting on sharesClick here to vote

Key Management of Relmada Therapeutics Inc

Name

Title

Ms. Gina DiGuglielmo

VP & Head of Clinical Operations

Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A.

Chief Medical Officer of Urology

Dr. Andrew Cutler

Senior Clinical Development Advisor

Dr. Richard M. Mangano Ph.D.

Consultant

Dr. Sergio Traversa M.B.A., Pharm.D.

CEO & Director

Mr. Maged S. Shenouda M.B.A., R.Ph.

Chief Financial Officer

Mr. Paul E. Kelly M.B.A.

COO & Director

FAQs

What is Relmada Therapeutics Inc share price today?

Relmada Therapeutics Inc share price today is $7.24 as on . Relmada Therapeutics Inc share today touched a day high of $7.59 and a low of $7.11.

What is the 52 week high and 52 week low for Relmada Therapeutics Inc share?

Relmada Therapeutics Inc share touched a 52 week high of $7.94 on and a 52 week low of $0.27 on . Relmada Therapeutics Inc stock price today i.e. is trending at $7.24,which is 8.82% down from its 52 week high and 2606.54% up from its 52 week low.

What is Relmada Therapeutics Inc's market capitalisation today?

Relmada Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Relmada Therapeutics Inc Stock (RLMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Relmada Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Relmada Therapeutics Inc Shares that will get you 0.2072 shares as per Relmada Therapeutics Inc share price of $7.24 per share as on April 27, 2026 at 8:43 pm IST.

What is the minimum amount required to buy Relmada Therapeutics Inc Stock (RLMD) from India?

Indian investors can start investing in Relmada Therapeutics Inc (RLMD) shares with as little as ₹94.19 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹941.90 in Relmada Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Relmada Therapeutics Inc share’s latest price of $7.24 as on April 27, 2026 at 8:43 pm IST, you will get 1.3812 shares of Relmada Therapeutics Inc. Learn more about fractional shares .

What are the returns that Relmada Therapeutics Inc has given to Indian investors in the last 5 years?

Relmada Therapeutics Inc stock has given -81.4% share price returns and 25.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?